Advancements in Proton and Carbon Ion Therapy for Precision Radiotherapy of Complex Tumors

Chandana, Gudur, Madhukar Zope, Das, Dev and Sahu

Health Leadership and Quality of Life, 2025, vol. 4, 850

Abstract: Precision radiation has changed a lot because of progress in proton and carbon ion therapy. This has made it much easier to treat complicated cancers. These particle treatments are becoming more well known for their ability to give highly targeted radiation doses that cause the least amount of damage to healthy tissues while still effectively targeting cancer. As a type of charged particle therapy, proton therapy uses protons instead of regular X-rays to treat cancer. It does this by taking advantage of the way protons are made, especially their Bragg peak, which is where they release their most energy. This makes it possible to deliver the amount more precisely, protecting healthy cells from too much radiation, especially in places that are hard to reach with regular photon-based treatment. Carbon ion treatment is a more advanced type of particle therapy that uses carbon ions, which are heavier than protons and have more mass and energy. These ions give a higher amount of radiation with more accuracy, which makes it more effective at treating tumors that are resistant to radiation, like those in the head, neck, and brain, as well as juvenile cancers. The biological efficiency of carbon ions is higher because they can hurt cells more severely than protons or regular X-rays. This means that they are better at controlling tumors in many therapeutic situations. Advanced technologies like synchrotrons and cyclotrons have made proton and carbon ion therapy more widely available. This means that patients can get these treatments more easily. Adding high-tech imaging methods like MRI and CT scans has also made these medicines more accurate, letting doctors watch patients in real time and change their treatment plans as needed. Using these technologies along with particle therapy has led to better treatment results, especially for tumors that are complicated and close to important structures.

Date: 2025
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:health:v:4:y:2025:i::p:850:id:850

DOI: 10.56294/hl2025850

Access Statistics for this article

More articles in Health Leadership and Quality of Life from AG Editor
Bibliographic data for series maintained by Javier Gonzalez-Argote ().